Alpha Cognition to Present Clinical Data at ASCP Annual Meeting
VANCOUVER, British Columbia & DALLAS — Alpha Cognition Inc. (Nasdaq: ACOG), a commercial-stage biopharmaceutical company developing therapies for neurodegenerative diseases, today announced it will present new clinical insights on cholinesterase inhibitors an
(Financial Post, 2025-10-06T12:35:53Z)